3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Phase 1
1
Status
Recruiting
1
Sponsor Class
FED
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
9
Gynecologic
4
Breast
3
Genitourinary
1
Conditions
Prostatic Neoplasms
1427
Carcinoma, Renal Cell
587
Urinary Bladder Neoplasms
368
Kidney Neoplasms
257
Carcinoma, Transitional Cell
190
Neoplasm Metastasis
163
Neoplasms
124
Melanoma
83
Breast Neoplasms
80
Carcinoma, Non-Small-Cell Lung
78
Testicular Neoplasms
67
Ovarian Neoplasms
62
Sarcoma
55
Urethral Neoplasms
51
Non-Muscle Invasive Bladder Neoplasms
51
Wilms Tumor
49
Lung Neoplasms
45
Colorectal Neoplasms
44
Uterine Cervical Neoplasms
39
Neuroblastoma
39
Penile Neoplasms
37
Pancreatic Neoplasms
37
Urologic Neoplasms
34
Recurrence
32
Lymphoma, Non-Hodgkin
32
Ureteral Neoplasms
28
Osteosarcoma
28
Testicular Germ Cell Tumor
26
Small Cell Lung Carcinoma
26
Head and Neck Neoplasms
26
Interventions
olaparib
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Fanconi Anemia, Complementation Group D1
×
Genitourinary
×
Clear all
NCT04038502
2025-08-20
COBRA
VA Office of Research and Development
Phase 2
Recruiting
100 enrolled